NCT01206764 2019-06-24
A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.
Novartis
Phase 4 Completed
Clinical Trials
5 trialsNCT02338570 2018-02-05
ORCHIDEE
Mario Negri Institute for Pharmacological Research
Phase 4 Terminated
NCT01266837 2017-11-14
MARC-2
iOMEDICO AG
Phase 4 Completed
NCT01514448 2017-07-19
Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib
Novartis
Phase 4 Completed
NCT02056587 2014-02-06
Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment
Kidney Cancer Research Bureau
Phase 4 Completed